Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Changes in SHBG levels don't predict diabetes risk reduction.

Promising cancer treatments were found, but the manufacturer closed.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

GLP-1 receptor agonists may help or harm hair health, needing more research.

Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

More research is needed to understand if GLP-1 agonists affect hair health.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Rosemary-based gel with metformin may effectively treat hair loss like minoxidil.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

GLP-1 RA medications may be linked to hair loss.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

Spironolactone might lower the chance of getting rosacea.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Semaglutide helps obese PCOS patients lose weight and improve health.

Finasteride may protect diabetic rats from oxidative stress and inflammation.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

GLP-1 RAs may help wound healing but can also cause faster facial aging and skin issues.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

Metformin can help diagnose and treat high testosterone levels in women, often due to insulin resistance rather than a tumor.

Tideglusib helps heal wounds in older skin.

GLP-1 therapies can cause hair loss, but hair often regrows after stopping or reducing the drug.